AIDS: A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.
| Name | AB1_HIV |
|---|---|
| Long name | Human immunodeficiency virus [HIV] disease |
| Hospital Discharge registry | ICD-10: B23/B24/B20/B22/B21, ICD-9: 0788A/0788B/0788C |
| Cause of Death registry | ICD-10: B21/B23/B20/B24/B22, ICD-9: 0788A/0788B/0788C |
| Include | AB1_HIV_INFECT_PARASITES, AB1_HIV_MALIGNANT, AB1_OTHER_DISEASE, AB1_OTHER_CONDITIONS, AB1_HIV_NOS |
| Level in the ICD-hierarchy | 2 |
| First defined in version | DF2 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 357 | 73 | 284 |
| Unadjusted prevalence (%) | 0.16 | 0.06 | 0.30 |
| Mean age at first event (years) | 41.27 | 40.16 | 41.55 |
| Case fatality at 5-years (%) | 0.56 | 0.00 | 0.70 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 31.0 | 29.0 | 31.5 |
| Recurrence at 6 months (%) | 92.44 | 79.45 | 95.77 |
before Human immunodeficiency virus [HIV] disease
after Human immunodeficiency virus [HIV] disease
Loading survival analyses plot…
Loading survival analyses table…